# Assess Efficacy and Safety of TachoComb H vs. Standard Surgical Treatment (i.e. Suturing) in Patients Undergoing Prostatectomy (TC-017-AU)

> **NCT00290836** · PHASE4 · COMPLETED · sponsor: **Nycomed** · enrollment: 120 (—)

## Conditions studied

- Control of Local Bleeding in Patients Undergoing Prostatectomy.

## Interventions

- **DRUG:** Human fibrinogen/thrombin and bovine aprotinin (TachoComb H)

## Key facts

- **NCT ID:** NCT00290836
- **Lead sponsor:** Nycomed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** —
- **Final completion:** 2007-08
- **Target enrollment:** 120 (—)
- **Last updated:** 2012-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00290836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00290836, "Assess Efficacy and Safety of TachoComb H vs. Standard Surgical Treatment (i.e. Suturing) in Patients Undergoing Prostatectomy (TC-017-AU)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00290836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*